Cardiol Therapeutics (CRDL) stock

Heart medicines , market cap $113M

Anti-inflammatory medicines for heart disease

Worth $113M

$1.02

-0.97%

As of Tuesday's close · Live for Pro members at the open

Why is CRDL down?

Down 31% in 3 months, 32% under its 50-day average.

Down more than its industry: the 274 other stocks in it fell a median 13% over the same 3 months.

−2Long-term trend below a falling 200-day average, down over two years

Tell me next time CRDL moves

Free account, no card. An optional alert when CRDL moves or its score changes.

Or see it live, free until Thursday morning. No account.

5 more things pulling CRDL's score down, for Pro members.

Quality Score

-6

Poor

In its industry

#227of 281

Biotech

Checks firing

1of 14

Trending down

From 52-week high

-56.4%

under its best in a year

CRDL's Quality Score was unchanged on Tue, Nov 10, at -6.

Follow CRDL's trial news. Pro members can get an alert when Cardiol Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CRDL files news on its trialSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextQ1 2027“Topline results are now anticipated in mid-2027, compared with our previous Q1 2027 guidance.”Trial data · SEC filing · Sep 23

Key facts on CRDL

Key facts on CRDL
Holding it back	A loss of CA$34M narrower than CA$37M a year earlier
Latest filing	20-F, Apr 20 Filed its annual report (20-F) for the year to Dec 31, 2021

1 more reason behind CRDL's -6, free with an account →4 more reasons behind CRDL's -6, for Pro members.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

CRDL catalysts

Coming up

What's next for CRDL, and how long its cash lasts

Next step the company has named

Q1 2027“Topline results are now anticipated in mid-2027, compared with our previous Q1 2027 guidance.”Trial data · SEC filing · Sep 23

What it means: the first look at a trial’s main results, as the company reports them.

1 more trial, 1 more milestone and 79 filings, for Pro members.

Cash runway Dec 31, 2025 balance sheet

CAD 21.4M in cash

Fewer than four quarters of cash flow are on file.

What it means: a runway is counted only when each of the last four quarters used cash. The company's estimate is “into Q1 2028” (8-K, Sep 23).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

For Pro members: every trade.

Get an alert when CRDL files news on its trialA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

How CRDL ranks in Biotech

CRDL is #227 of 281 by Quality Score.

How CRDL ranks in Biotech
Rank	Stock	Checks	Quality Score
1	ONCBeOne Medicines	8/14	24
2	VCELVericel	8/14	22
3	ETONEton Pharmaceutcials	9/14	20
	CORTCorcept Therapeutics		Open for its score
	CRBPCorbus Pharmaceuticals		Open for its score
	CRLCharles River Laboratories International		Open for its score
	CRSPCRISPR Therapeutics		Open for its score
227	CRDLCardiol Therapeutics	1/14	-6

CRDL has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on CRDL, and all 14 on every stock.Get in free →

CRDL RSI today: 34.0, below its 50-day and 200-day averages

Not scored

RSI 34.0, MACD above signal, below both averages. Not scored.13 readings

The deep dive on CRDL

What it does and how it makes money1 findingFor Pro members1 finding on what CRDL does and how it makes money, for Pro members
Who holds and trades it1 findingFor Pro members1 finding on who holds and trades CRDL, for Pro members

About Cardiol Therapeutics

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

18 employeescardiolrx.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on CRDL and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn CRDL's score around: 7 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

See CRDL's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: CRDL's Quality Score is -6 (Poor), #227 of 281 in Biotech.

What does CRDL's Quality Score say?

CRDL scores -6 today, which Breakaway calls Poor. It is #227 of 281 in Biotech by Quality Score, with 1 of 14 chart checks firing. Down 31% in 3 months, 32% under its 50-⁠day average. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is CRDL's Quality Score?

CRDL scores -6 today, which Breakaway calls Poor (below zero). That is #227 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CRDL's -6.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.